Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data

• Jérôme Lambert,
• Roberta Di Blasi,
• Florence Rabian,
• Marie-Emilie Dourthe,
• André Baruchel,
• Catherine Thiéblemont,
• Nicolas Boissel,
• Vincent Levy,
• Marie-Quitterie Picat,
• Sylvie Chevret

Affiliations

Jérôme Lambert

1 Biostatistic Department, Saint Louis Hospital (APHP), Paris, France

Roberta Di Blasi

4 Hemato-oncology Department, Saint Louis Hospital (APHP), Paris, France

Florence Rabian

3 Paris Cité University, Paris, France

Marie-Emilie Dourthe

7 Department of Pediatric Hematology and Immunology, AP-HP, Hôpital Universitaire Robert Debré, Paris, France

André Baruchel

3 Paris Cité University, Paris, France

Catherine Thiéblemont

3 Paris Cité University, Paris, France

Nicolas Boissel

3 Paris Cité University, Paris, France

Vincent Levy

2 ECSTRRA Team, UMR1153, Inserm, Université Paris Cité, Paris, France

Marie-Quitterie Picat

1 Biostatistic Department, Saint Louis Hospital (APHP), Paris, France

Sylvie Chevret

1 Biostatistic Department, Saint Louis Hospital (APHP), Paris, France